Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial (vol 29, pg 2121, 2023 )

被引：1

作者：

Routy, Bertrand

Lenehan, John G.

Miller Jr, Wilson H.

Jamal, Rahima

Messaoudene, Meriem

Daisley, Brendan A.

Hes, Cecilia

Al, Kait F.

Martinez-Gili, Laura

Puncochar, Michal

Ernst, Scott

Logan, Diane

Belanger, Karl

Esfahani, Khashayar

Richard, Corentin

Ninkov, Marina

Piccinno, Gianmarco

Armanini, Federica

Pinto, Federica

Krishnamoorthy, Mithunah

Figueredo, Rene

Thebault, Pamela

Takis, Panteleimon

Magrill, Jamie

Ramsay, Leeann

Derosa, Lisa

Marchesi, Julian R.

Parvathy, Seema Nair

Elkrief, Arielle

Watson, Ian R.

Lapointe, Rejean

Segata, Nicola

Haeryfar, S. M. Mansour

Mullish, Benjamin H.

Silverman, Michael S.

Burton, Jeremy P.

Vareki, Saman Maleki

机构：

[1] Research Center of the Centre Hospitalier de l’Université de Montréal,Hematology

[2] Montréal (CRCHUM),Oncology Division, Department of Medicine

[3] Centre Hospitalier de l’Université de Montréal (CHUM),Department of Oncology

[4] Western University,Departments of Oncology and Medicine

[5] Lawson Health Research Institute,Department of Microbiology & Immunology

[6] Lady Davis Institute of the Jewish General Hospital,Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine

[7] Segal Cancer Centre,Section of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine

[8] McGill University,Department of Computational, Cellular and Integrative Biology

[9] Western University,Department of Pathology and Laboratory Medicine

[10] Canadian Centre for Human Microbiome and Probiotics Research,Department of Metabolism, Digestion and Reproduction, Faculty of Medicine

[11] Peter Brojde Lung Cancer Center,Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction

[12] Jewish General Hospital,Rosalind and Morris Goodman Cancer Institute

[13] St Mary’s Hospital Campus,Cancer Medicine Department

[14] Imperial College London,Department of Medicine, Division of Infectious Diseases

[15] Imperial College London,Division of Infectious Diseases

[16] University of Trento,Department of Biochemistry

[17] Western University,Département de Médecine, Faculté de Médecine

[18] National Phenome Centre,Department of Medicine, Division of Clinical Immunology and Allergy

[19] Imperial College London,Department of Surgery, Division of General Surgery

[20] Imperial College London,Departments of Gastroenterology and Hepatology

[21] McGill University,Department of Medical Biophysics

[22] Gustave Roussy Cancer Campus,undefined

[23] Gustave Roussy,undefined

[24] Institut National de la Santé Et et de la Recherche Médicale (INSERM) U1015,undefined

[25] ClinicObiome,undefined

[26] Equipe Labellisée—28 Ligue Nationale contre le Cancer,undefined

[27] Université Paris-Saclay,undefined

[28] Western University,undefined

[29] St Joseph’s Health Care,undefined

[30] McGill University,undefined

[31] Université de Montréal,undefined

[32] Western University,undefined

[33] Western University,undefined

[34] St Mary’s Hospital,undefined

[35] Imperial College Healthcare NHS Trust,undefined

[36] Western University,undefined

[37] Ontario Institute of Cancer Research,undefined

来源：

NATURE MEDICINE | 2024年 / 30卷 / 03期

关键词：

D O I：

10.1038/s41591-023-02650-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：604 / 604

页数：1

共 50 条

[1] Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy
John G. Lenehan
Wilson H. Miller
Rahima Jamal
Meriem Messaoudene
Brendan A. Daisley
Cecilia Hes
Kait F. Al
Laura Martinez-Gili
Michal Punčochář
Scott Ernst
Diane Logan
Karl Belanger
Khashayar Esfahani
Corentin Richard
Marina Ninkov
Gianmarco Piccinno
Federica Armanini
Federica Pinto
Mithunah Krishnamoorthy
Rene Figueredo
Pamela Thebault
Panteleimon Takis
Jamie Magrill
LeeAnn Ramsay
Lisa Derosa
Julian R. Marchesi
Seema Nair Parvathy
Arielle Elkrief
Ian R. Watson
Rejean Lapointe
Nicola Segata
S.M. Mansour Haeryfar
Benjamin H. Mullish
Michael S. Silverman
Jeremy P. Burton
Saman Maleki Vareki
[J]. Nature Medicine, 2023, 29 : 2121 - 2132
[2] Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Routy, Bertrand
Lenehan, John G.
Miller, Wilson H.
Jamal, Rahima
Messaoudene, Meriem
Daisley, Brendan A.
Hes, Cecilia
Al, Kait F.
Martinez-Gili, Laura
Puncochar, Michal
Ernst, Scott
Logan, Diane
Belanger, Karl
Esfahani, Khashayar
Richard, Corentin
Ninkov, Marina
Piccinno, Gianmarco
Armanini, Federica
Pinto, Federica
Krishnamoorthy, Mithunah
Figueredo, Rene
Thebault, Pamela
Takis, Panteleimon
Magrill, Jamie
Ramsay, LeeAnn
Derosa, Lisa
Marchesi, Julian R.
Parvathy, Seema Nair
Elkrief, Arielle
Watson, Ian R.
Lapointe, Rejean
Segata, Nicola
Haeryfar, S. M. Mansour
Mullish, Benjamin H.
Silverman, Michael S.
Burton, Jeremy P.
Vareki, Saman Maleki
[J]. NATURE MEDICINE, 2023, 29 (08) : 2121 - +
[3] Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy
John G. Lenehan
Wilson H. Miller
Rahima Jamal
Meriem Messaoudene
Brendan A. Daisley
Cecilia Hes
Kait F. Al
Laura Martinez-Gili
Michal Punčochář
Scott Ernst
Diane Logan
Karl Belanger
Khashayar Esfahani
Corentin Richard
Marina Ninkov
Gianmarco Piccinno
Federica Armanini
Federica Pinto
Mithunah Krishnamoorthy
Rene Figueredo
Pamela Thebault
Panteleimon Takis
Jamie Magrill
LeeAnn Ramsay
Lisa Derosa
Julian R. Marchesi
Seema Nair Parvathy
Arielle Elkrief
Ian R. Watson
Rejean Lapointe
Nicola Segata
S.M. Mansour Haeryfar
Benjamin H. Mullish
Michael S. Silverman
Jeremy P. Burton
Saman Maleki Vareki
[J]. Nature Medicine, 2024, 30 : 604 - 604
[4] Fecal microbiota transplantation followed by anti-PD-1 treatment in patients with advanced melanoma.
Miller, Wilson H.
Routy, Bertrand
Jamal, Rahima
Ernst, D. Scott
Logan, Diane
Esfahani, Khashayar
Belanger, Karl
Elkrief, Arielle
Lapointe, Rejean
Thebault, Pamela
Ponce, Mayra
Parvathy, Seema Nair
Messaoudene, Meriem
Silverman, Micheal
Maleki, Saman
Lenehan, John Gordon
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[5] A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: Fecal microbiota transplantation
Meng, Yiming
Sun, Jing
Zhang, Guirong
[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 200
[6] Fecal Microbiota Transplantation plus Anti-PD-1 Is Safe in a First-line Setting
不详
[J]. CANCER DISCOVERY, 2023, 13 (09) : 1957 - 1957
[7] Role of Anti-PD-1 Antibodies in Advanced Melanoma: The Era of Immunotherapy
Sahni, Sakshi
Valecha, Gautam
Sahni, Ankit
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2018, 10 (12)
[8] Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Davar, Diwakar
Dzutsev, Amiran K.
McCulloch, John A.
Rodrigues, Richard R.
Chauvin, Joe-Marc
Morrison, Robert M.
Deblasio, Richelle N.
Menna, Carmine
Ding, Quanquan
Pagliano, Ornella
Zidi, Bochra
Zhang, Shuowen
Badger, Jonathan H.
Vetizou, Marie
Cole, Alicia M.
Fernandes, Miriam R.
Prescott, Stephanie
Costa, Raquel G. F.
Balaji, Ascharya K.
Morgun, Andrey
Vujkovic-Cvijin, Ivan
Wang, Hong
Borhani, Amir A.
Schwartz, Marc B.
Dubner, Howard M.
Ernst, Scarlett J.
Rose, Amy
Najjar, Yana G.
Belkaid, Yasmine
Kirkwood, John M.
Trinchieri, Giorgio
Zarour, Hassane M.
[J]. SCIENCE, 2021, 371 (6529) : 595 - +
[9] Role of DAMPs for immunoresistance towards anti-PD-1 immunotherapy in advanced melanoma
Geidel, G.
Bauer, A. T.
Wicklein, D.
Schumacher, U.
Schneider, S. W.
Gebhardt, C.
[J]. EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E110 - E110
[10] Fecal microbiota transplantation combined with anti-PD-1 inhibitor for unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor.
Park, Sook Ryun
Kim, Gihyeon
Kim, Yunjae
Cho, Beomki
Kim, Sang-Yeob
Do, Eun-Ju
Bae, Dong-Jun
Kweon, Mi-Na
Song, Joon Seon
Park, Hansoo
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

← 1 2 3 4 5 →